-
All
27
-
Harvard Business School
8
-
Harvard College
4
-
Harvard Faculty of Arts and Sciences
2
-
Harvard Graduate School of Arts and Sciences
4
-
Harvard Graduate School of Design
1
-
Harvard John A. Paulson School of Engineering and Applied Sciences
1
-
Harvard Medical School
14
-
Harvard T.H. Chan School of Public Health
4
-
I'm a post-doc
1
-
Non-Harvard Affiliate
7
-
Cellforma
Developing life-saving, first-of-its-kind regenerative cell therapies to overcome the unmet need for donor lungs.
-
Modulate Bio
Developing therapies to treat neurological disorders, including Essential Tremor, epilepsy, and anxiety.
-
Promakhos Therapeutics
Developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.
-
AbscoTx
An image-guided, injectable, intratumoral drug delivery platform that creates a personalized “cancer vaccine” to treat local and metastatic tumors.
-
Aperture Bio
Realizing orders-of-magnitude improvements in speed and sensitivity, Aperture rapidly analyzes proteins in whole cells to map immune interactions.
-
BioDevek
Improving clinical outcomes following internal surgeries using degradable biomaterials.
-
CartaBio Inc
A single-cell precision medicine techbio that uses proprietary spatial biology and AI to decode novel disease biology.
-
Day Zero Diagnostics
Developing technologies to help control healthcare-associated infections (HAIs), where antibiotic resistant organisms can be especially dangerous.
-
GC Therapeutics
Using synthetic biology to program stem cells into any cell type with best-in-class efficiency, speed, and scalability.
-
Kern Systems
Leveraging enzymes and cutting-edge software to store digital data in DNA at scale.
-
Kinnos
Adding color to disinfectants, visualizing surface coverage for more effective and efficient cleaning in healthcare settings.
-
Manifold Bio
Designing tissue-specific medicines in living systems from the start by combining high-throughput in-vivo studies with AI-guided protein design.
-
Tectonic Therapeutic, Inc.
Transforming the discovery of novel drugs addressing targets in the GPCR family.
-
Transcera
Transforming chronic disease treatment through improved biologic drug delivery.